Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Structured Exercise Training in Newly Diagnosed Multiple SclerosisCompleted
NCT05957809NAUpdated May 25, 2025
Sponsor: Istanbul University - Cerrahpasa
Multiple Sclerosis
Turkey (Türkiye)
REtinal Markers In Neuroinflammatory Diseases ("REMIND")Recruiting
NCT06369766N/AUpdated May 23, 2025
Sponsor: University Hospital, Basel, Switzerland
Multiple Sclerosis · Neuroinflammatory Diseases
Switzerland
Retinal Neuro-vascular Coupling in Patients With Multiple SclerosisRecruiting
NCT03401879NAUpdated May 23, 2025
Sponsor: Medical University of Vienna
Multiple Sclerosis, Relapsing-Remitting · Optic Neuritis
Austria
The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With MSCompleted
NCT06987994NAUpdated May 23, 2025
Sponsor: Istinye University
Multiple Sclerosis · Multiple Sclerosis (MS) - Relapsing-remitting · Virtual Reality
Turkey (Türkiye)
Interest of a Musical Intervention on Stress Induced During Botulinum Toxin Injections in Spasticity (MUSIBOT)Recruiting
NCT06920524NAUpdated May 23, 2025
Sponsor: University Hospital, Clermont-Ferrand
Stroke · Multiple Sclerosis · Spinal Cord Injury · Head Trauma Injury
France
An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCADCompleted
NCT06987851Phase 3Updated May 23, 2025
Sponsor: Biocad
Multiple Sclerosis
Russia
Trunk Restraint in Multiple SclerosisCompleted
NCT06982833NAUpdated May 21, 2025
Sponsor: Zonguldak Bulent Ecevit University
Multiple Sclerosis · Healthy Control
Turkey (Türkiye)
FIT-ATOMIC Exercise Feasibility TrialNot Yet Recruiting
NCT06870968NAUpdated May 21, 2025
Sponsor: The Hospital for Sick Children
Neuroinflammatory Diseases · Multiple Sclerosis
United States, Canada
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple SclerosisRecruiting
NCT06981013NAUpdated May 20, 2025
Sponsor: University of St. Augustine for Health Sciences
Multiple Sclerosis
United States
Online Program to Reduce Depression in MSCompleted
NCT02740361NAUpdated May 20, 2025
Sponsor: Charite University, Berlin, Germany
Multiple Sclerosis
United States, Germany
Reproductive Options in Inherited Skin DiseasesEnrolling By Invitation
NCT06330324N/AUpdated May 18, 2025
Sponsor: Maastricht University Medical Center
Ichthyosis · Palmoplantar Keratoses · Epidermolysis Bullosa · Ectodermal Dysplasia
Netherlands
Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRIRecruiting
NCT06955832N/AUpdated May 18, 2025
Sponsor: Benha University
Multiple Sclerosis
Egypt
Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive CounsellingRecruiting
NCT06330350N/AUpdated May 18, 2025
Sponsor: Maastricht University Medical Center
Quality of Life · Ichthyosis · Palmoplantar Keratoses · Epidermolysis Bullosa
Netherlands
Territorial Implementation and Evaluation of a Multiple Sclerosis Expert Patient ProgramCompleted
NCT04988880NAUpdated May 16, 2025
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Multiple Sclerosis · Quality of Life · Patient Empowerment · Patient Activation
Spain
Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple SclerosisEnrolling By Invitation
NCT05706220N/AUpdated May 16, 2025
Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Multiple Sclerosis · Clinically Isolated Syndrome · Relapsing Remitting Multiple Sclerosis · Progressive Multiple Sclerosis
Spain
Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With OfatumumabCompleted
NCT04869358Phase 4Updated May 16, 2025
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
Germany
A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With OfatumumabTerminated
NCT04878211Phase 4Updated May 16, 2025
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis (RMS)
United States
A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in ChinaCompleted
NCT05658484Phase 4Updated May 16, 2025
Sponsor: Biogen
Multiple Sclerosis
China
Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation ToolkitCompleted
NCT04468919NAUpdated May 16, 2025
Sponsor: Oregon Health and Science University
Amyotrophic Lateral Sclerosis · Brainstem Stroke · Muscular Dystrophies · Parkinson's Disease and Parkinsonism
United States
Internet Delivered Cognitive Rehabilitation for Mild Cognitive ImpairmentsEnrolling By Invitation
NCT06973018NAUpdated May 15, 2025
Sponsor: Aniko Bartfai
Traumatic Brain Injury · Stroke · Multiple Sclerosis · Parkinsons Disease (PD)
Sweden
Evaluation of the Microbiome in Multiple SclerosisTerminated
NCT05844826NAUpdated May 15, 2025
Sponsor: Nimble Science Ltd.
Multiple Sclerosis
Canada
Swiss Multiple Sclerosis RegistryRecruiting
NCT02980640N/AUpdated May 15, 2025
Sponsor: Swiss Multiple Sclerosis Registry
Multiple Sclerosis
Switzerland
A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple SclerosisTerminated
NCT02975349Phase 2Updated May 14, 2025
Sponsor: EMD Serono Research & Development Institute, Inc.
Relapsing-remitting Multiple Sclerosis
Bulgaria, Czechia, Poland, Russia, Serbia +3 more
TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated ParticipantsCompleted
NCT05236777N/AUpdated May 13, 2025
Sponsor: Biogen
Multiple Sclerosis
Czechia
Exercise Therapy in Multiple SclerosisCompleted
NCT04294979NAUpdated May 13, 2025
Sponsor: IRCCS San Raffaele Roma
Multiple Sclerosis
Italy

Previous page Next page